￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long is the general resistance to Fulvestrant/Fuxitan?

2026-02-01 22:25:32

Check Details
Interpret the medical insurance reimbursement policy of Gefapixant Citrate

2026-02-01 22:25:32

Check Details
Determining the interaction between Stiripentol and Valproic acid

2026-02-01 22:25:32

Check Details
Analyze the action targets and mechanisms of mitapivat-Pyrukynd

2026-02-01 22:25:32

Check Details
Pegcetacoplan-Empaveli Drug Interactions and Precautions

2026-02-01 22:25:32

Check Details
Injection frequency of Fulvestrant/Fuxit and how long to take an injection

2026-02-01 22:25:32

Check Details
Instructions for proper storage of Gefapixant Citrate

2026-02-01 22:25:32

Check Details
When will Stiripentol be officially launched in China?

2026-02-01 22:25:32

Check Details
Analyze the advantages of the targeted drug Futibatinib

2026-02-01 22:25:32

Check Details
Are there health risks associated with long-term use of mitapivat-Pyrukynd?

2026-02-01 22:25:32

Check Details
Interpret the relevant information about Pegcetacoplan-Empaveli’s inclusion in medical insurance

2026-02-01 22:25:32

Check Details
FDA approves selumetinib for symptomatic, inoperable adult patients with plexiform neurofibromatosis type 1

2026-02-01 22:25:32

Check Details
Category
相关知识